A study for the effects of intakes of a food ingredient on UV irradiated skin conditions in healthy adults -Randomized, double-blind, placebo-controlled, parallel-group study
- Conditions
- one (Healthy Adults)
- Registration Number
- JPRN-UMIN000052632
- Lead Sponsor
- Kirin Holdings Company, Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 80
Not provided
Subjects 1who are currently, or have been within the past 4 weeks, undergoing drug treatment for any disease, or who regularly use pharmaceutical or quiasi-drug products for purposes without disease treatment 2who have been diagnosed with photosensitivity 3who take drugs that affect the photosensitivity 4who have any factors that may affect the results of the measurement 5who are scheduled to undergo or have undergone within the past 4 weeks any special skincare treatment 6who continuously use skincare products, or health foods that emphasize efficacy related to the efficacy studied in this study 7who have changed or newly started using basic cosmetics or sunscreen products within the past 4 weeks 8who are unable to quit the intake of supplements or health foods 9who cannot control their intake of yogurt and intestinal preparations 10who have been within the past 4 weeks or will be exposed to much UV radiation than they are exposed to in their daily lives 11who are at risk of developing allergies to foods 12who continuously use drugs for freckles, pigmentation and melasma 13who work night shifts or day/night shifts 14who are likely to change their lifestyle 15who are undergoing treatment for the treatment or prevention, or who are judged to require treatment 16who continuously use or take anti-inflammatory drugs more than once a month 17who have a history of serious diseases (glucose metabolism, lipid metabolism, etc.) 18who are undergoing climacteric symptom or postmenopausal hormone replacement therapy, or those who have been undergoing such therapy for at least 6 months 19who refuse to disclose their biological sex 20with a history of alcohol or drug dependence 21with a smoking habit 22who are pregnant or lactating, or those who are likely to become pregnant 23who participate in with in the past 4 weeks or plan to participate in any other human study 24who are jedged unsuitable as subjects by the chief physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method